In a joint venture with the UAE, the Ministry of National Health Services (NHS) declared on Saturday that it had made headway towards opening a plasma-farming facility (PFF) in Islamabad.
A delegation from Dubai’s ruling family, including Naser Ali Khameis Alyammahi, Chief Operations Officer of Hayat BioTech, and Ahmed bin Dalmook bin Juma Al Maktoum, visited Pakistan to talk about possible new endeavours in health, vaccines, and research.
The group met with Shehbaz Sharif, the PM, Abdul Qadir Patel, the Minister of Health, and other representatives to discuss potential funding possibilities in plasmapheresis and vaccine development.
A coordination office at the Regional Blood Center in Islamabad has been formally opened by Sheikh Maktoum in an effort to forge strong ties between the facility and the ministry.
The delegation reportedly showed interest in funding plasma farming according to WHO standards in Pakistan. This investment will be crucial because the majority of hospital blood banks in Pakistan provide blood treatments, and the production and utilisation of plasma are not clearly separated.
Abdul Qadir Patel, Pakistan’s health minister, praised the UAE’s offer and emphasised the value of cooperation between the two nations in the field of medicine because it will significantly ease Pakistan’s people’s suffering.
According to him, this collaboration, along with the UAE’s keen interest in blood banking service reform, especially the establishment of a plasma farming and harvesting facility in Pakistan, will help the nation provide top-notch healthcare.
With a 20% drop in plasma donations between 2020 and 2021 and an increase in demand for plasma-based therapies, there is increasing concern about the global plasma shortage.
Pharmaceutical products that address uncommon, chronic, and possibly fatal medical conditions are produced with the help of plasma. Pakistan’s population is heavily reliant on plasma-based therapies for survival, and the plasma collection business is expanding quickly.